Effects of PHA-665752 and vemurafenib combination treatment on inï¿½vitro and murine xenograft growth of human colorectal cancer cells with BRAFV600E mutations-Reference-Cited by-同舟云学术

Effects of PHA-665752 and vemurafenib combination treatment on inï¿½vitro and murine xenograft growth of human colorectal cancer cells with BRAFV600E mutations

Published:2018-01-10 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Zhi Jie¹,Li Zhongxin²,Lv Jian²,Feng Bo¹,Yang Donghai²,Xue Liang²,Zhao Zhaolong²,Zhang Yanni²,Wu Jianhua³,Jv Yingchao³,Jia Yitao¹

Affiliation:

1. Department of Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China

2. Second Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China

3. Experimental Animal Center, The Forth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of²²⁵Ac-Labeled Anti-EGFR Radioimmunoconjugate in EGFR-Positive Kirsten Rat Sarcoma Viral Oncogene and BRAF Mutant Colorectal Cancer Models;Journal of Nuclear Medicine;2024-02-15

2. Comparison of Apoptotic Effects of Rapamycin and Vemurafenib in Colorectal Cancer;Uludağ Üniversitesi Tıp Fakültesi Dergisi;2023-12-31

3. easyPheno: An easy-to-use and easy-to-extendPythonframework for phenotype prediction using Bayesian optimization;Bioinformatics Advances;2023-01-01

4. Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers;Journal of Cancer Research and Clinical Oncology;2021-12-01

5. Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer;Critical Reviews in Oncology/Hematology;2021-04